FluoroFinder
Private Company
Total funding raised: $1.8M
Overview
FluoroFinder operates a SaaS platform that leverages AI and machine learning to automate and optimize the design of fluorescence-based experiments for life science research. The company's core value proposition is aggregating product data from over 78 suppliers and using proprietary algorithms to ensure reagent compatibility with specific laboratory instruments, thereby streamlining a traditionally manual and error-prone process. It primarily serves academic core facilities, pharmaceutical researchers, and biotech labs, generating revenue through platform access. Founded in 2016 and based in Salt Lake City, FluoroFinder is a private, revenue-generating company positioned as a workflow efficiency tool in the research tools and diagnostics sector.
Technology Platform
AI-powered software platform for designing fluorescence-based experiments (flow cytometry, microscopy). Analyzes millions of marker-fluorophore-instrument combinations to recommend optimized reagent panels from a aggregated database of 78+ suppliers.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competitors include free panel design tools from major flow cytometry vendors (BD Biosciences' Panel Designer, Thermo Fisher's Panel Selector, Bio-Rad's Panel Builder), which are often limited to their own products. Other third-party software like CytaExpert and standalone academic algorithms also exist. FluoroFinder's key differentiator is its supplier-agnostic, comprehensive database and its AI-driven optimization for specific instrument configurations.